CURRICULUM VITAE
Gilbert G. Fareau MD
Gilbert G. Fareau MD
Associate Professor
Department of Medicine
Division of Endocrinology
Department of Medicine
Division of Endocrinology
OFFICE ADDRESS: |
Hub for Collaborative Medicine |
8701 Watertown Plank Road |
Milwaukee, WI 53226 |
MEDICAL COLLEGE TEACHING ACTIVITIES: |
Resident and Fellow Education |
04/30/2020 Endocrine Fellows Lecture: Thyroid Board Review |
11/25/2020 Academic Half Day Lecture for Interns: Thyroid Disease |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Fareau GG, Vassilopoulou-Sellin R. Late disease recurrence in patients diagnosed with and treated for differentiated thyroid carcinoma Endocrinologist. November 2006;16(6):329-334. |
2. Fareau GG, Vassilopoulou-Sellin R. Late Disease Recurrence in Patients Diagnosed with and Treated for Differentiated Thyroid Carcinoma The Endocrinologist. Fareau GG, Vassilopoulou-Sellin R. 2006; 16(6):329-34. |
3. Fareau GG, Maldonado M, Oral E, Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism. 2007 May;56(5):670-5. |
4. Núñez R, Sellin RV, Fareau GG, Drucker CR. Skin rash after radioactive iodine caught on a cell phone camera. Thyroid. 2007 Mar;17(3):277-8. |
5. Fareau GG, Vassilopoulou-Sellin R. Diagnostic challenges in adrenocortical carcinoma: recommendations for surveillance after surgical resection of selected adrenal nodules. Endocr Pract. 2007 Oct;13(6):636-41. |
6. Fareau GG, Vassilopoulou-Sellin R. Hypercortisolemia and infection. Infect Dis Clin North Am. 2007 Sep;21(3):639-57, viii. |
7. Fareau GG, Lopez A, Stava C, Vassilopoulou-Sellin R. Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. Anticancer Drugs. 2008 Jul;19(6):637-44. |
8. Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. Ann Surg Oncol. 2012 Dec;19(13):4217-22. |
9. Carr AA, Yen TW, Fareau GG, Cayo AK, Misustin SM, Evans DB, Wang TS. A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation. J Am Coll Surg. 2014 Oct;219(4):757-64. |
10. Lai V, Yen TW, Rose BT, Fareau GG, Misustin SM, Evans DB, Wang TS. The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer. Ann Surg Oncol. 2015 Dec;22(13):4181-6. |
11. Glenn JA, Yen TW, Fareau GG, Carr AA, Evans DB, Wang TS. Institutional experience with lateral neck dissections for thyroid cancer. Surgery. 2015 Oct;158(4):972-8; discussion 978-80. |
12. Fareau GG. Management of patients with metastatic medullary thyroid carcinoma: The role for systemic therapy Medullary Thyroid Cancer. 20 July 2016:157-164. |
13. Lai V, Yen TW, Doffek K, Carr AA, Carroll TB, Fareau GG, Evans DB, Wang TS. Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism. Ann Surg Oncol. 2016 Jul;23(7):2310-4. |
14. Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, Campbell BH, Doffek KL, Evans DB, Wang TS. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls. Thyroid. 2018 Nov;28(11):1462-1467. |
